Sulbutiamina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sulbutiamina" in Spanish language version.

refsWebsite

Global rank Spanish rank

16nih.gov

4^th place

7doi.org

2^nd place

3archive.org

6^th place

5^th place

archive.org

Bettendorff L, Weekers L, Wins P, Schoffeniels E (1990). «Injection of sulbutiamine induces an increase in thiamine triphosphate in rat tissues». Biochem Pharmacol 40 (11): 2557-60. PMID 2268373. doi:10.1016/0006-2952(90)90099-7.
Layzer RB (1998). «Asthenia and the chronic fatigue syndrome». Muscle Nerve 21 (12): 1609-11. PMID 9843061. doi:10.1002/(SICI)1097-4598(199812)21:12<1609::AID-MUS1>3.0.CO;2-K.
Micheau J, Durkin TP, Destrade C, Rolland Y, Jaffard R (1985). «Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation». Pharmacol Biochem Behav 23 (2): 195-8. PMID 4059305. doi:10.1016/0091-3057(85)90555-6.

doi.org

dx.doi.org

Bettendorff L, Weekers L, Wins P, Schoffeniels E (1990). «Injection of sulbutiamine induces an increase in thiamine triphosphate in rat tissues». Biochem Pharmacol 40 (11): 2557-60. PMID 2268373. doi:10.1016/0006-2952(90)90099-7.
Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L (2008). «Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives». BMC Pharmaco 8: 10. PMC 2435522. PMID 18549472. doi:10.1186/1471-2210-8-10.
Douzenis A, Michopoulos I, Lykouras L (2006). «Sulbutiamine, an 'innocent' over the counter drug, interferes with therapeutic outcome of bipolar disorder». World J Biol Psychiatry 7 (3): 183-5. PMID 16861144. doi:10.1080/15622970500492616.
Lonsdale D (2006). «A Review of the Biochemistry, Metabolism and Clinical Benefits of Thiamin(e) and Its Derivatives». Evid Based Complement Alternat Med 3 (1): 49-59. PMC 1375232. PMID 16550223. doi:10.1093/ecam/nek009.
Layzer RB (1998). «Asthenia and the chronic fatigue syndrome». Muscle Nerve 21 (12): 1609-11. PMID 9843061. doi:10.1002/(SICI)1097-4598(199812)21:12<1609::AID-MUS1>3.0.CO;2-K.
Micheau J, Durkin TP, Destrade C, Rolland Y, Jaffard R (1985). «Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation». Pharmacol Biochem Behav 23 (2): 195-8. PMID 4059305. doi:10.1016/0091-3057(85)90555-6.
Bizot JC, Herpin A, Pothion S, Pirot S, Trovero F, Ollat H (2005). «Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task». Prog Neuropsychopharmacol Biol Psychiatry 29 (6): 928-35. PMID 15951087. doi:10.1016/j.pnpbp.2005.04.035.

nih.gov

ncbi.nlm.nih.gov

Bettendorff L, Weekers L, Wins P, Schoffeniels E (1990). «Injection of sulbutiamine induces an increase in thiamine triphosphate in rat tissues». Biochem Pharmacol 40 (11): 2557-60. PMID 2268373. doi:10.1016/0006-2952(90)90099-7.
Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L (2008). «Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives». BMC Pharmaco 8: 10. PMC 2435522. PMID 18549472. doi:10.1186/1471-2210-8-10.
Tiev KP, Cabane J, Imbert JC (1999). «[Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo]». Rev Med Interne 20 (10): 912-8. PMID 10573727.
Van Reeth O (1999). «Pharmacologic and therapeutic features of sulbutiamine». Drugs Today (Barc) 35 (3): 187-92. PMID 12973384.
Douzenis A, Michopoulos I, Lykouras L (2006). «Sulbutiamine, an 'innocent' over the counter drug, interferes with therapeutic outcome of bipolar disorder». World J Biol Psychiatry 7 (3): 183-5. PMID 16861144. doi:10.1080/15622970500492616.
Lonsdale D (2006). «A Review of the Biochemistry, Metabolism and Clinical Benefits of Thiamin(e) and Its Derivatives». Evid Based Complement Alternat Med 3 (1): 49-59. PMC 1375232. PMID 16550223. doi:10.1093/ecam/nek009.
Lonsdale D (2004). «Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent». Med Sci Monit 10 (9): 199-203. PMID 15328496.
Bettendorff L, Wins P. (1994). «Mechanism of thiamine transport in neuroblastoma cells. Inhibition of a high affinity carrier by sodium channel activators and dependence of thiamine uptake on membrane potential and intracellular ATP». J Biol Chem 269 (20): 14379-85. PMID 8182042.
Fujihira E, Tarumoto Y, Ajioka M, Mori T, Nakazawa M (1973). «[Analgesic effect of o-isobutyrylthiamine disulfide on experimentally induced pain]». Yakugaku Zasshi 93 (3): 388-91. PMID 4737603.
Layzer RB (1998). «Asthenia and the chronic fatigue syndrome». Muscle Nerve 21 (12): 1609-11. PMID 9843061. doi:10.1002/(SICI)1097-4598(199812)21:12<1609::AID-MUS1>3.0.CO;2-K.
Shah SN; Sulbutiamine Study Group (2003). «Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia». J Assoc Physicians India 51: 891-5. PMID 14710977.
Levin OS, Slizkova IuB (2007). «[The use of enerion in the treatment of asthenic disorders in patients after mild cranio-cerebral trauma]». Zh Nevrol Psikhiatr Im S S Korsakova 107 (5): 44-8. PMID 18379496.
Micheau J, Durkin TP, Destrade C, Rolland Y, Jaffard R (1985). «Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation». Pharmacol Biochem Behav 23 (2): 195-8. PMID 4059305. doi:10.1016/0091-3057(85)90555-6.
Bizot JC, Herpin A, Pothion S, Pirot S, Trovero F, Ollat H (2005). «Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task». Prog Neuropsychopharmacol Biol Psychiatry 29 (6): 928-35. PMID 15951087. doi:10.1016/j.pnpbp.2005.04.035.
Ollat, H; B Laurent, S Bakchine, BF Michel, J Touchon, B Dubois (2007). «[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease». Encephale 33 (2): 211-15. PMID 17675917.
Lôo H, Poirier MF, Ollat H, Elatki S (2000). «[Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes]». L'Encéphale (en francés) 26 (2): 70-5. PMID 10858919. Consultado el 6 de octubre de 2012.